Eton Pharmaceuticals (ETON) grants 80,000 RSUs tied to $72.36 hurdle
Rhea-AI Filing Summary
Erdogan-Trinkaus Ipek reported acquisition or exercise transactions in this Form 4 filing.
Eton Pharmaceuticals granted Chief Commercial Officer Ipek Erdogan-Trinkaus 80,000 performance-vested restricted stock units on July 31, 2026 under its 2018 equity incentive plan. Each unit entitles the holder to one common share if the stock’s closing price reaches $72.36 or higher for one trading day within three years; otherwise the entire award, the only 80,000 shares issuable, is forfeited on July 31, 2029.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Erdogan-Trinkaus Ipek
Role
Chief Commercial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 80,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 80,000 shares (Direct)
Footnotes (1)
- F1. On July 31, 2026, the reporting person was granted 80,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date. If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range.
Key Figures
RSUs Granted: 80,000 units
Grant Price: $0.0000 per share
Market Condition Price: $72.36 per share
+3 more
6 metrics
RSUs Granted
80,000 units
Performance-vested restricted stock units granted on July 31, 2026
Grant Price
$0.0000 per share
Reported transaction price per share for the RSU award
Market Condition Price
$72.36 per share
Closing price hurdle required for vesting on one trading day
Award Term
3 years
Condition may be satisfied any time prior to third anniversary of grant date
Forfeiture Date
July 31, 2029
Date on which the award is forfeited if the market condition is not met
Shares Issuable
80,000 shares
Maximum and only number of common shares issuable under the award
Key Terms
performance-vested restricted stock units, equity incentive plan, market condition
3 terms
performance-vested restricted stock units financial
"was granted 80,000 performance-vested restricted stock units granted under the Issuer's 2018"
equity incentive plan financial
"restricted stock units granted under the Issuer's 2018 equity incentive plan."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
market condition financial
"If this market condition is not satisfied prior to such date, the award"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider equity award did ETON grant to Ipek Erdogan-Trinkaus?
Eton Pharmaceuticals granted Chief Commercial Officer Ipek Erdogan-Trinkaus 80,000 performance-vested restricted stock units. Each unit represents the right to acquire one share of common stock, subject to a stock price performance condition described in the award terms.
What is the stock price condition for the 80,000 RSUs reported by ETON?
The 80,000 restricted stock units vest only if Eton’s common stock closes at or above $72.36 per share for one trading day. This market condition must be met within three years of the July 31, 2026 grant date.
Over what time frame can the ETON RSU market condition be satisfied?
The market condition can be satisfied at any time within three years of the July 31, 2026 grant date. A single trading day with a closing price at or above $72.36 per share is sufficient for the award to vest in full.
What happens to the 80,000 ETON RSUs if the price condition is not met?
If the $72.36 per share market condition is not met within three years, the entire 80,000-unit award is forfeited. The RSUs then terminate without consideration on July 31, 2029, and no shares are issued under this grant.
Is there any range or tiered payout on the ETON RSU award?
No. The disclosure states that 80,000 shares is the maximum and only number of shares issuable. There is no target, threshold, or maximum range; the award either vests in full upon meeting the condition or is fully forfeited.